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Our previous studies have shown that S6K1 and S6K2 protein kinases form the complexes with newly identified
adaptor protein TDRD7, which is involved in regulation of cytoskeleton dynamics, mRNA transport, protein
translation, piRNAs processing and transposons silensing. Aim.Determination the subcellular localization of
S6K1-TDRD7 and S6K2-TDRD7 protein complexes. Methods. Immunofluorescense microscopy was used to
study co-localization of S6K1/S6K2 and TDRD7 in HEK293, HEPG2 cell lines as well as in rat primary
hippocampal neurons using primary polyclonal anti-S6K1 antibodies, monoclonal anti-S6K2 and anti- TDRD7
antibodies. Results. It was found that S6K1 is co-localized with TDRD7 in perinuclear region of HEK293 cells.
S6K1 and S6K2 were also co-localized with TDRD7 in perinuclear region of HEPG2 cells and in soma of
primary rat hippocampal neurons. Conclusions. In this report we provide an additional experimental evidences
of possible S6K1-TDRD7 and S6K2-TDRD7 complexes formation in cells of different tissue origins that may
reflect their potential physiological importance. However, elucidation of the exact composition of these comple-
xes and their role in cell physiology requires additional studies.
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Introduction. The ribosomal protein S6 kinases (S6Ks)
are serine/threonine kinases, which belong to the fa-
mily of AGC kinases [1]. The activation of S6Ks is co-
ordinated via the mitogen-stimulated PI3K and the nut-
rient sensing mTOR pathways [2]. S6Ks are involved
in the regulation of diverse cellular processes and func-
tions including protein synthesis, RNA splicing, trans-
cription, cell growth and survival [1, 2]. Mammalian
cells express two S6K forms: S6K1 and S6K2, and each
of them exists in long (S6K1/I and S6K2/I) and short
(S6K1/II and S6K2/II) splicing variants.
The predominantly expressed in cells short (70 kDa)
isoform of S6K1 is localized mainly but not exclusive-
ly within the cytoplasm. A nuclear localization sequence
(NLS) found within the N-terminal (23 aa) extension of
long S6K1 isoform (85 kDa) may target it to the nucleus
[3, 4]. Similarly, the long (56 kDa) isoform of S6K2 dif-
fers from the short (54 kDa) splicing version by the pre-
sence of the NLS [1, 4] located within the N-terminal
(13 aa) extension. At the same time, both S6K2 iso-
forms contain additional NLS at the C-terminus, which
can determine their nuclear localization [5, 6].
While S6K1 and S6K2 share a very high degree of
similarity in their kinase domains (more then 80 %), the
N- and C-terminal regulatory regions exhibit only 20 %
identity. These regions contain different binding motifs
and regulatory sites, which may recruit S6K isoforms
to different cellular complexes/compartments and/or
modulate their stability and enzymatic activity. At pre-
sent, more than twenty substrates have been identified
for S6Ks, but only few of them have well defined func-
tional significance [2].
A number of S6Ks-binding partners have been im-
plicated in the regulating of their kinase activity, inclu-
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ding small GTPases Rac1 and cdc42, protein kinases
PDK1 and PKC, protein phosphatases PP2A and PP1
and cytoskeleton protein neurabin [2, 7–9].
Previously, in the course of yeast-two hybrid scree-
ning of HeLa cDNA library by S6K1 as a bite we have
identified a novel S6K1/2 binding partner – Tudor do-
main containing 7 protein (TDRD7) [10]. Further studi-
es confirmed the formation of S6K1/TDRD7 and S6K2/
TDRD7 complexes in vivo [11]. In addition we have re-
vealed the existence of several S6K-mediated phospho-
rylation sites within TDRD7 protein sequence that was
confirmed by in vitro kinase assay [11]. TDRD7 protein
is known as a scaffold protein with molecular weight
about 130 kDa. It was originally identified as a binding
partner of Ser/Thr PCTAIRE2 kinase [12]. Subsequent
investigations have led to the discovery of TDRD7 in a
complex with ik3/Cables – cyclin-dependent kinase
binding protein [13].
It was demonstrated recently that loss-of-function
mutations in TDRD7 as well as Tdrd7 nullizygosity may
cause cataracts or glaucoma formation in mammals and
also cause an arrest in spermatogenesis [14].
TDRD7 is localized in cytoplasm and together with
other members of Tudor-family (TDRD1/MTR-1,
TDRD6) has been implicated in the formation of polar/
germinal granules (nuage), which contain Dicer and
microRNAs. These structures are involved in the micro
RNA pathway and the formation of a ribonucleoprotein
complex in spermatids [12, 15–17]. In addition it was
suggested the involvement of TDRD7 in the complex
with TACC1-chTOG-Aurora kinase A, which controls
mRNA fate in conjunction with microtubule organiza-
tion and the maintenance of cell polarity [18].
Our previous studies allowed us to determine
TDRD7 distribution in HEK293 cells [19]. Using anti-
TDRD7 monoclonal antibodies (E6) we had demonstra-
ted that a large fraction of this protein was localized in
the nucleus and perinuclear region of HEK293 cells.
In this report, we present the data regarding pos-
sible co-localization of S6K1 and S6K2 with TDRD7
protein in specific subcellular compartments of HEK293,
HEPG2 cells, and rat primary hippocampal neurons.
Materials and methods. Antibodies. Monoclonal
anti-TDRD7 (specific to 181–411 aa sequence), anti-
S6K2 polyclonal (specific to the C-terminal region of
S6K2) and anti-S6K1 polyclonal antibodies (specific
to the C-terminal region of S6K1) have been described
previously [20, 21].
Anti-mouse and anti-rabbit secondary antibodies
labelled with FITC Alexa Fluor 488 (green) and Alexa
Fluor 568 (red) («Invitrogen», USA) respectively were
used for immunocytochemical analysis. To decrease
the autofluorescence background the preparations were
incubated for 30 min in 10 mM CuSO4 and 50 mM of
CH3COONH4 at pH 5.0. Control preparations were in-
cubated without primary antibodies.
Cell culture and immunocytochemical analysis.
HEK293 (human embryonic kidney) and HEPG2 (hu-
man hepatocellular carcinoma) cells were obtained from
the American Type Culture Collection and maintai-
ned in DMEM supplemented with 10 % foetal bovine
serum («HyClone», UK), penicillin (200 U/ml) and
streptomycin (200 mg/ml).
Culture of rat primary hippocampal neurons was
kindly gifted from laboratory of molecular biophysics,
Bogomoletz Institute of Physiology.
For immunofluorescent staining, HEK293 cells we-
re grown in tissue culture chambers («Nunc», Denmark),
fixed with 3.7 % paraformaldehyde in PBS, and permea-
bilized with PBS-T (0.2 % Tween-20) three times for 5
min. Unspecific binding was blocked by 45 min incuba-
tion of cells with 10 % FBS diluted in PBS-T. After-
wards, incubation with primary and secondary antibodies
was performed as described previously [22]. Fluorescent-
ly labelled proteins were visualized using a Zeiss LSM510
confocal microscope, and the images were analyzed using
the LSM510 image browser software [23]. Nuclei were
stained with Hoechst 33258 («Sigma», USA).
Results and discussion. It has been already demon-
strated that the 23- and 13-amino-acid extensions at the
N-termini of S6K1/I and S6K2/I contain nuclear loca-
lization signals (NLSs) that target these isoforms consti-
tutively to the nucleus [24, 25]. It is known that S6K1/
II isoform is predominantly cytosolic, but it can also be
accumulated in the nucleus when cells are treated with
inhibitor of nuclear export in human cells leptomycin B
(LMB) [26]. It is believed that the presence of an addi-
tional NLS at the C terminus of the S6K2/II determines
its predominantly nuclear localization. Nucleocytoplas-
mic shuttling has been reported for both cytoplasmic
forms of S6K, but the mechanisms of its regulation ha-
ve not been elucidated [27–29].
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It was reported previously that TDRD7 was localized
on the mitochondria outer membrane and in cytoplas-
mic structures called chromatoid bodies [16, 28]. Our re-
cent studies with employment of immunofluorescent-
confocal microscopy and anti-TDRD7 (E6) monoclonal
antibody indicated the presence of TDRD7 not only in
the cytoplasm, but in the nucleus as well. Especially
strong TDRD7 positive signal was observed in the peri-
nuclear zone and in the region of mitotic spindle forma-
tion [19].
The obtained data are in accordance with the obser-
vation of another research group which had demonstr
ated that the pool of endogenous TDRD7 is present in
the nucleus of COS 7 cells overexpressing TDRD7
[13].
To determine possible co-localization sites of
TDRD7 with S6K1 and S6K2 we applied an immuno-
cytofluorescent analysis. For the first time, we detected
co-localization of TDRD7 with S6K1 kinase in HEK293
cells. According to our observations S6K1/TDRD7
complexes are distributed within cytoplasm and nuclei
of the cells and a large amount of S6K1 and TDRD7 are
concentrated in perinuclear region and peripheral zone
of HEK293 cells (Fig. 1). Such co-localization of S6K1
and TDRD7 could reflect physiological impor- tance of
possible S6K1-TDRD7 complex formation.
The results obtained encouraged us to enquire whe-
ther TDRD7 and S6K1 are co-localized in the other cell
types. It was revealed that endogenous S6K1 is co-loca-
lized with TDRD7 protein and demonstrates weak level
of co-localization in the cytoplasm of HEPG2 cells,
partly in perinuclear region, but not so apparently as in
HEK293 (Fig. 2, A, see inset).
Further, taking into account that TDRD7 also forms
complex with S6K2 [11], we decided to check whether
TDRD7 is co-localized with S6K2 kinase.
It has been already mentioned that both S6K2 iso-
forms contain additional NLS at the C-terminus, which
determines their predominant nuclear localization in
quiescent cells [6]. So, the next question was whether
co-localization of TDRD7 with S6K2 kinase will be dif-
ferent from that observed for S6K1.
According to our data, TDRD7 may be co-localized
with S6K2 in HEPG2 cells, predominantly in perinuc-
lear region (Fig. 2, B, see inset). Such co-localization
was similar to that observed in HEK293 cells for S6K1.
Finally, as far as TDRD7 is known to be overex-
pressed in neural tissue [12], we decided to examine the
possible subcellular co-localization of S6K1-TDRD7
and S6K2-TDRD7 in rat hippocampal primary neurons
culture (Fig. 3, see inset).
Immunocytochemical analysis revealed that S6K1-
TDRD7 and S6K2-TDRD7 complexes are localized pre-
dominantly in soma of neurons rather than in neurits.
It has been reported previously, that in quiescent
cells S6K1 is mostly concentrated in cytoplasm [5, 9,
27, 29]. Nevertheless, keeping in mind that S6K1 long
isoform contains NLS, some fractions of S6K1 were ex-
pected to be present in nucleus. According to our obser-
vation a large amount of S6K1 and TDRD7 are concen-
trated in perinuclear region of HEK293. Co-localiza-
tion of S6K1 and TDRD7 in HEPG2 was weak, whe-
reas co-localization of TDRD7 and S6K2 in these cells
was much more stronger.
Our observation suggests some physiological im-
portance of the S6K1/TDRD7 and S6K2/TDRD7 comp-
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Fig. 1. TDRD7 co-localized with S6K1 in HEK293 cells. HEK293 cells were fixed with 3.7 % FA; S6K1 (green) (B) and TDRD7 (red) (C) content
(subcellular localization) was revealed using corresponding antibodies. As secondary antibodies Alexa-Fluore 488 (green) and Alexa Fluor 568
(red) antibodies were used. Nuclei were stained with Hoechst 33258 (A). Picture (D) represents a merge of signals. White arrows indicate
co-localization signals of TDRD7 and S6K1. Oc.10; ob. 100
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Fig. 2. TDRD7 co-localized with S6K1 (A) and S6K2 (B) in HEPG2 cells. HEPG2 cells were fixed with 3.7 % FA. S6K1 and S6K2 (red in A and
B, respectively) (a) and TDRD7 (green) (c) content was revealed using corresponding antibodies; as secondary antibodies Alexa-Fluore 488 and
Alexa Fluor 568 (green and red, respectively) antibodies were used. Nuclei were stained with Hoechst 33258 (b); d – a merge of signals; white
arrows indicate co-localization signals of TDRD7 and S6K1 (A) and TDRD7 and S6K2 (B); oc.10; ob. 100
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Fig. 3. TDRD7 co-localized with S6K1 (A) and S6K2 (B) in rat hyppocampal primary neurons culture. Cells were fixed with 3.7 % FA. S6K1 and
S6K2 (red in A and B, respectively) (a) and TDRD7 (green) (c) content was revealed using corresponding antibodies; as secondary antibodies
Alexa-Fluore 488 and Alexa Fluor 568 (green and red respectively) antibodies were used. Nuclei were stained with Hoechst 33258 (b); d – a merge
of signals; white arrows indicate co-localization signals of TDRD7 and S6K1 (A) and TDRD7 and S6K2 (B); oc.10; ob. 100
lexes formation. We could assume that perinuclear lo-
calization of both complexes may reflect a possible role
of TDRD7 in the regulation of S6K1 and/or S6K2 nuc-
leo-cytoplsmic shuttling.
In addition, taking into account that TDRD7 serves as
a substrate for S6K1 as well as for S6K2 in vitro [11],
we may speculate that S6Ks also can influence TDRD7
intracellular localization and its functions in vivo.
In this report we provide the additional experimen-
tal evidences of possible S6K1-TDRD7 and S6K2-
TDRD7 complexes formation in cells of different tis-
sue origin. Taking into consideration our previous re-
sults [10, 11] the obtained data also support the idea of
possible physiological importance of these complexes
formation. However, determination of the exact compo-
sition of complexes and elucidation of their role in cells
require additional studies.
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Î. Ì. Ñêîðîõîä, À. ². Õîðóæåíêî, Â. Â. Ô³ëîíåíêî
Àäàïòîðíèé á³ëîê TDRD7 ñï³âëîêàë³çóºòüñÿ ç ê³íàçàìè S6
ðèáîñîìíîãî á³ëêà S6K1 ³ S6K2 ó êë³òèííèõ ë³í³ÿõ ð³çíîãî
òêàíèííîãî ïîõîäæåííÿ
Ðåçþìå
Ðàí³øå íàìè ïîêàçàíî, ùî ïðîòå¿íîâ³ ê³íàçè S6K1 ³ S6K2 ôîðìó-
þòü êîìïëåêñè ç íåùîäàâíî ³äåíòèô³êîâàíèì àäàïòîðíèì á³ëêîì
TDRD7, çàëó÷åíèì äî ðåãóëÿö³¿ äèíàì³êè öèòîñêåëåòó, òðàíñïîð-
òó ìÐÍÊ, òðàíñëÿö³¿ á³ëê³â, ïðîöåñèíãó ï³ÐÍÊ òà ñàéëåíñèíãó
òðàíñïîçîí³â.Ìåòà. Âèçíà÷åííÿ ñóáêë³òèííî¿ ëîêàë³çàö³¿ ìîæëè-
âèõ êîìïëåêñ³â S6K1– TDRD7 ³ S6K2–TDRD7. Ìåòîäè. Êë³òèíí³
ë³í³¿ HEK293, HEPG2 ³ ïåðâèííà êóëüòóðà íåéðîí³â ã³ïîêàìïó ùó-
ðà âèêîðèñòàíî äëÿ ³ìóíîôëóîðåñöåíòíîãî àíàë³çó ³ç çàñòîñóâàí-
íÿì ïîë³êëîíàëüíèõ àíòè-S6K1 àíòèò³ë òà ìîíîêëîíàëüíèõ àíòè-
S6K2 ³ àíòè-TDRD7 àíòèò³ë. Ðåçóëüòàòè. Âèÿâëåíî, ùî S6K1
ñï³âëîêàë³çóºòüñÿ ç TDRD7 ïåðåâàæíî â íàâêîëîÿäåðí³é çîí³ êë³-
òèí ÍÅÊ293. Îêð³ì òîãî, S6K1 ³ S6K2 ñï³âëîêàë³çóþòüñÿ ç TDRD7
òàêîæ ïåðåâàæíî ó íàâêîëîÿäåðí³é ä³ëÿíö³ êë³òèí HEPG2 òà â
ñîì³ ïåðâèííî¿ êóëüòóðè íåéðîí³â ã³ïîêàìïó ùóðà. Âèñíîâêè.
Îòðèìàíî äîäàòêîâ³ åêñïåðèìåíòàëüí³ ñâ³ä÷åííÿ ùîäî ôîðìó-
âàííÿ êîìïëåêñ³â S6K1– TDRD7 ³ S6K2–TDRD7 ó êë³òèíàõ ð³çíîãî
òêàíèííîãî ïîõîäæåííÿ, ùî, éìîâ³ðíî, ï³äòâåðäæóº ¿õíþ ô³ç³î-
ëîã³÷íó çíà÷óù³ñòü. Âò³ì, äëÿ âèçíà÷åííÿ òî÷íîãî ñêëàäó êîìï-
ëåêñ³â ³ ç’ÿñóâàííÿ ¿õíüî¿ ðîë³ ó êë³òèíàõ íåîáõ³äí³ äîäàòêîâ³ äî-
ñë³äæåííÿ.
Êëþ÷îâ³ ñëîâà: S6K1, S6K2, TDRD7, ³ìóíîöèòîôëóîðåñöåíò-
íèé àíàë³ç.
À. Í. Ñêîðîõîä, À. È. Õîðóæåíêî, Â. Â. Ôèëîíåíêî
Àäàïòîðíûé áåëîê TDRD7 êoëîêàëèçèðóåòñÿ ñ êèíàçàìè S6K1
è S6K2 ðèáîñîìíîãî áåëêà S6 â êëåòî÷íûõ ëèíèÿõ ðàçëè÷íîãî
òêàíåâîãî ïðîèñõîæäåíèÿ
Ðåçþìå
Ðàíåå íàìè ïîêàçàíî, ÷òî ïðîòåèíîâûå êèíàçû S6K1 è S6K2
ôîðìèðóþò êîìïëåêñû ñ íåäàâíî èäåíòèôèöèðîâàííûì àäàïòîð-
íûì áåëêîì TDRD7, ó÷àñòâóþùèì â ðåãóëÿöèè äèíàìèêè öèòî-
ñêåëåòà, òðàíñïîðòå ìÐÍÊ, òðàíñëÿöèè áåëêà, ïðîöåññèíãå ïèÐÍÊ
è ñàéëåíñèíãå òðàíñïîçîíîâ. Öåëü. Îïðåäåëåíèå ñóáêëåòî÷íé ëî-
êàëèçàöèè âîçìîæíûõ êîìïëåêñîâ S6K1–TDRD7 è S6K2–TDRD7.
Ìåòîäû. Êëåòî÷íûå ëèíèè HEK293, HEPG2 è ïåðâè÷íàÿ êóëüòó-
ðà íåéðîíîâ ãèïïîêàìïà êðûñû èñïîëüçîâàíû äëÿ èììóíîôëóîðåñ-
öåíòíîãî àíàëèçà ñ ïðèìåíåíèåì ïîëèêëîíàëüíûõ àíòè-S6K1 àí-
òèòåë è ìîíîêëîíàëüíûõ àíòè-S6K2 è àíòè-TDRD7 àíòèòåë. Ðå-
çóëüòàòû. Îáíàðóæåíî, ÷òî S6K1 êîëîêàëèçóåòñÿ ñ TDRD7 ïðå-
èìóùåñòâåííî â îêîëîÿäåðíîé çîíå êëåòîê ÍÅÊ293. Êðîìå òîãî,
S6K1 è S6K2 êîëîêàëèçóþòñÿ ñ TDRD7 òàêæå ïðåèìóùåñòâåííî
â îêîëîÿäåðíîé îáëàñòè êëåòîê HEPG2 è â ñîìå ïåðâè÷íîé êóëü-
òóðû íåéðîíîâ ãèïïîêàìïà êðûñû. Âûâîäû. Ïîëó÷åíû äîïîëíè-
òåëüíûå ýêñïåðèìåíòàëüíûå äîêàçàòåëüñòâà ôîðìèðîâàíèÿ êîìï-
ëåêñîâ S6K1– TDRD7 è S6K2–TDRD7 â êëåòêàõ ðàçíîãî òêàíåâîãî
ïðîèñõîæäåíèÿ, ÷òî, âîçìîæíî, ïîäòâåðæäàåò èõ ôèçèîëîãè÷åñ-
êóþ çíà÷èìîñòü. Îäíàêî äëÿ îïðåäåëåíèÿ òî÷íîãî ñîñòàâà êîìï-
ëåêñîâ è âûÿñíåíèÿ èõ ðîëè â êëåòêàõ íåîáõîäèìû äîïîëíèòåëü-
íûå èññëåäîâàíèÿ.
Êëþ÷åâûå ñëîâà: S6K1, S6K2, TDRD7, èììóíîöèòîôëóîðåñ-
öåíòíûé àíàëèç.
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